Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ensartinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Has Accepted the New Drug Application (NDA) for Ensartinib
    FDA Has Accepted the New Drug Application (NDA) for Ensartinib

    13 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240313675039/en

    BUSINESSWIRE
    13 Mar 2024
    Share Share
    Ensartinib Secured Its First Approval for 1st Line Treatment in ALK+ NSCLC
    Ensartinib Secured Its First Approval for 1st Line Treatment in ALK+ NSCLC

    22 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220322006197/en

    BUSINESSWIRE
    22 Mar 2022
    Share Share
    Takeda offers value-based pricing for Alunbrig
    Takeda offers value-based pricing for Alunbrig

    09 Nov 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/marketing/takeda-value-based-drug-pricing-lung-cancer-alunbrig-pfizer-xalkori-discount-rebate

    Angus Liu FIERCEPHARMA
    09 Nov 2021
    Share Share
    Vanderbilt Oncologists Publish Results of First Study
    Vanderbilt Oncologists Publish Results of First Study

    29 Oct 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191029005146/en/Vanderbilt-Oncologists-Publish-Results-Study-Demonstrate-Clinical

    BUSINESSWIRE
    29 Oct 2019
    Share Share
    The Lancet Respiratory Medicine Published Study Shows Ensartinib
    The Lancet Respiratory Medicine Published Study Shows Ensartinib

    18 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/the-lancet-respiratory-medicine-published-study-shows-ensartinib-holds-promise-as-a-new-treatment-option-for-alk-positive-non-small-cell-lung-cancer-nsclc-/?s=95

    BIOSPACE
    18 Oct 2019
    Share Share
    The Lancet Respiratory Medicine Published Study of Ensartinib
    The Lancet Respiratory Medicine Published Study of Ensartinib

    17 Oct 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191017006005/en

    BUSINESSWIRE
    17 Oct 2019
    Share Share